Expression of the apoptosis inhibitor protein survivin in primary laryngeal carcinoma and cervical lymph node metastasis

Anticancer Research

Volumn 26, Issue 5 B, 2006, Pages 3813-3817

  Marioni, Gino ^a,b   Bertolin, Andy ^a   Giacomelli, Luciano ^a   Marchese Ragona, Rosario ^a   Savastano, Marina ^a   Calgaro, Nicola ^a   Marino, Filippo ^a   De Filippis, Cosimo ^a   Staffieri, Alberto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Section of Otolaryngology   (Italy)

Author keywords

Apoptosis inhibitor; Laryngeal carcinoma; Lymph node metastasis; Prognosis; Survivin

Indexed keywords

SURVIVIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CERVICAL LYMPH NODE; CLINICAL ARTICLE; FEMALE; HUMAN; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NECK; NEOPLASM PROTEINS;

EID: 33750695631     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Altieri DC: Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22: 8581-8589, 2003.
2. Badran A, Yoshida A, Wano Y, Imamura S, Kawai Y, Tsutani H, Inuzuka M and Ueda T: Expression of the antiapoptotic gene survivin in chronic myeloid leukemia. Anticancer Res 23: 589-592, 2003.
3. Schultz IJ, Kiemeney LA, Witjes JA, Schalken JA, Willems JL, Swinkels DW and de Kok JB: Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence. Anticancer Res 23: 3327-3331, 2003.
4. Lo Muzio L, Staibano S, Pannone G, Mignogna MD, Mariggio' A, Salvatore G, Chieffi P, Tramontano D, De Rosa G and Altieri DC: Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Experimental and Molecular Pathology 70: 249-254, 2001.
5. Tanaka C, Uzawa K, Shibahara T, Yokoe H, Noma H and Tanzawa H: Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis. J Dent Res 82: 607-611, 2003.
6. Lo Muzio L, Pannone G, Staibano S, Mignogna MD, Rubini C, Mariggio MA, Procaccini M, Ferrari F, De Rosa G and Altieri DC: Survivin expression in oral squamous cell carcinoma. Br J Cancer 89: 2244-2248, 2003.
7. Lo Muzio L, Pannone G, Leonardi R, Staibano S, Mignogna MD, De Rosa G, Kudo Y, Takata T and Altieri DC: Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res 82: 923-928, 2003.
8. Marioni G, Bedogni A, Giacomelli L, Ferraro SM, Bertolin A, Facco E, Staffieri A and Marino F: Survivin expression is significantly higher in pN+ oral and oropharyngeal primary squamous cell carcinomas than in pNO carcinomas. Acta Otolaryngol (Stockh) 125: 1218-1223, 2005.
9. Weinman EC, Roche PC, Kasperbauer JL, Cha SS, Sargent DJ, Cheville J, Murphy LM, Chen L, Wettstein PJ, Gostout B, Ferrone S and Strome SE: Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma. Cancer 97: 2203-2211, 2003.
10. Xiang Y, Yao H, Wang S, Hong M, He J, Cao S, Min H, Song E and Guo X: Prognostic value of Survivin and Livin in nasopharyngeal carcinoma. Laryngoscope 116: 126-130, 2006.
11. International Union Against Cancer: TNM Classification of Malignant Tumours. 5th ed. New York, NY: Wiley-Liss, 1997.
12. Dong Y, Sui L, Watanabe Y, Sugimoto K and Tokuda M: Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications. Anticancer Res 22: 2377-2383, 2002.
13. Pizem J, Cör A and Gale N: Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation. Histopathology 45: 180-186, 2004.
14. Sharma H, Sen S, Mathur M, Bahadur S and Singh N: Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers. Head Neck 26: 733-740, 2004.
15. Nix P, Cawkwell L, Patmore H, Greenman J and Stafford N: Bcl-2 expression predicts radiotherapy failure in laryngeal cancer. Br J Cancer 92: 2185-2189, 2005.
16. Marioni G, Ottaviano G, Marchese-Ragona R, Giacomelli L, Bertolin A, Zanon D, Marino F and Staffieri A: High nuclear expression of apoptosis inhibitor protein survivin is associated with disease recurrence and poor prognosis in laryngeal basaloid squamous cell carcinoma. Acta Otolaryngol (Stockh) 126: 197-203, 2006.
17. Lo Muzio L, Campisi G, Giovannelli L, Ammatuna P, Greco I, Staibano S, Pannone G, De Rosa G, Di Liberto C and D'Angelo M: HPV DNA and survivin expression in epithelial oral carcinogenesis: a relationship? Oral Oncol 40: 736-741, 2004.
18. Grabowski P, Kühnel T, Muhr-Wilkenshoff, Heine B, Stein H, Hüpfner M, Germer CT and Scherübl H: Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer 88: 115-119, 2003.
19. Wang Z-N, Xu H-M, Jiang L, Zhou X, Lu C and Zhang X: Expression of survivin in primary and metastatic gastric cancer, cells obtained by laser capture microdissection. World J Gastroenterol 10: 3094-3098, 2004.